Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosome Liquid Dressing for Recovery After Nd:YAG Laser Treatment
NCT06279039Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Sep 2022
- Primary completion
- Aug 2024
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Randomised, double-blind trial of Exosome liquid dressing in seborrheic keratosis (SK), sponsored by Nanjing First Hospital. Primary endpoints: Global Aesthetic Improvement Scale at 56 days and Dermatology Quality of Life Index at 56 days. Started Sep 2022; status: recruiting.
02
Drugs
Exosome liquid dressing
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on NCT06279039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06279039.